Artificial Intelligence | News | Insights | AiThority
Bitcoin
$11,329.37
-515.21
(-4.35%)
Ethereum
$375.02
-18.91
(-4.8%)
Ripple
$0.28
-0.01
(-4.74%)
Litecoin
$53.69
-4.35
(-7.49%)
EOS
$2.96
-0.25
(-7.81%)
Cardano
$0.14
-0.01
(-6.18%)
Stellar
$0.10
-0.01
(-5.28%)
NEO
$13.59
-0.89
(-6.15%)
NEM
$0.06
-0
(-0.38%)
DigitalCash
$87.27
-8.44
(-8.82%)
Tether
$1.00
-0
(-0.12%)
Binance Coin
$21.15
-1.31
(-5.83%)
QTUM
$2.67
-0.24
(-8.15%)
Verge
$0.01
0
(+14.04%)
Ontology
$0.75
-0.08
(-9.98%)
ZCash
$81.13
-8.64
(-9.62%)
Steem
$0.22
-0
(-0.88%)

Datametrex Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

0 5

Datametrex AI Limited is pleased to announce that is has signed a Strategic Partnership and Development Agreement with Transpharm Canada Inc.

Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio. Datametrex will be providing the COVID-19 test kits. TCI will be providing all other services including but not limited to the collection of specimens, transport of specimens, and processing test results.

Recommended AI News: IBM and Red Hat Launch New Edge Computing Solutions for the 5G Era

TCI will design, engineer, and develop a fully integrated suite of testing systems that will include in the field and lab testing protocols using TCI’s fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility. TCI lab has a current capacity to process 2,304 nucleic acid COVID-19 real-time detection kits (the “Kits”) every 24 hrs using CFX96 real-time PCR detection system machines and is scalable to over 10,000 test kits every 24 hrs.

Transpharm will develop a Point of Care Diagnostic Kit System (the “TCI System”) with clear protocols of specimen collection, specimen handling, and specimen container labeling including the patient’s full name, date of collection, and one other unique identifier such as date of birth or government issued health card number. Transpharm will also develop a procedure focused around delivery related to specimen transport media tube protocols including to ensure cap on tube is tightly sealed, shipped at 2-8°C, 26-46°F to the TCI laboratory testing facility.

Recommended AI News: Financial Strength Should Be a Key Consideration When Choosing the Right Cybersecurity Vendor in the COVID-19 Era

Datametrex is committed to helping Canada and Canadians find a safe and secure way to get people out of lockdown and back to work. The Company first identified the need for high quality test kits back in April, since then, it has established relationships with four South Korean manufacturers of nucleic acid test kits. The Company quickly identified that both public and private corporations are not fully equipped to administer and process the test kits on their own. As a result, the Company quickly sourced a qualified lab testing company to partner with that will provide customers with a turnkey solution to administer tests efficiently, safely, and accurately. The Company believes testing is going to be key to re-opening the economy in a safe fashion, and also believes in providing Canadians with the best solution.

“By participating in this project, Datametrex reaffirms its commitment to helping it customers, shareholders, families, and the Canadian public. This project hopes to aid in the reopening of businesses, travel, places of worship, community spaces, and social and cultural events in a safe and economic way,” said Marshall Gunter, CEO of Datametrex.

Dr. Alexander MacGregor, founder and President of TCI, stated, “Transpharm is pleased to join in the COVID-19 fight with Datametrex and provide a world class testing facility for this endeavour. This world pandemic poses an unprecedented threat to the way that most people live their daily lives. There are several obvious steps we can take to ensure that no one must choose between their health and leaving their homes, and that begins with testing. Transpharm has the people, the equipment, and world class lab space to meet the enormous demand coming and to get the job done.”

Recommended AI News: HashCash to Help Banking Sector With Blockchain-Based Digital Identity to Streamline Remote Operations

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.